JLVDB & DB et Analyses et mesures biomédicales
0885.835.969 · rovalta.com · 26/09/2026
JLVDB & DB et Analyses et mesures biomédicales
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOJLVDB & DB et Analyses et mesures biomédicales is a Private limited company incorporated in 2006. Its main activity is: Technical testing and analysis. Its registered office is in Linkebeek.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0885.835.969
- Incorporation
- 21/12/2006
- Legal form
- Private limited company
- Registered office
- Avenue des Villas 102
1630 Linkebeek · FlandreSee on map - Contributed capital
- 1 500,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 2 filingsTrend over 2 financial years
| 2025 | 2024 | ||
|---|---|---|---|
| Income statement | |||
| Gross margin | 96,2 k € | -41.4% | 164,2 k € |
| EBITDA | 92,7 k € | -41.7% | 159,1 k € |
| Operating result | 88,1 k € | -42.6% | 153,6 k € |
| Net result | 63 k € | +289% | -33,4 k € |
| Balance sheet | |||
| Equity | 141,5 k € | +3.2% | 137,1 k € |
| Total assets | 193,3 k € | +6.8% | 181 k € |
| Cash | 175 k € | – | |
| Debts | 51,8 k € | +17.9% | 43,9 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20241 active
Active mandates
Financials
Full financial information
Source · NBB| 2025 | 2024 | |
|---|---|---|
| Type of account | Micro model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/11/2023 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 |
| Length of the financial year | 12 months | 14 months |
| Filing date | 29/06/2026 | 05/04/2025 |
| General meeting | 19/06/2026 | 03/04/2025 |
| Currency of the financial year | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 2 filingsValuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20241 active
Active mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other31/12/2025Aanneming van nieuwe statuten in het Nederlands
- Registered office18/12/2025Transfert du siège de la société en Flandre
- Mandates29/01/2024STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DENOMINATION - DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE - ANNEE COMPTABLE
- Mandates11/08/2015DENOMINATION - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
- Other03/01/2007RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202563 k €↑
- 2025Name changeJLVDB & DB ANALYSES ET MESURES BIOMEDICALES
- 2024Annual accounts 2024-33,4 k €
- 2024Name changeJLVDB & DB et Analyses et mesures biomédicales
- 21/12/2006IncorporationPrivate limited company